Miguel Gil Gil
- Oncology top 10%
- Cancer Research
- Pulmonary and Respiratory Medicine
- Molecular Biology
- Pathology and Forensic Medicine
- Co-authors
- Lorena de la PeñaSteven J. IsakoffEva CiruelosBegoña BermejoJosé Luís Passos‐CoelhoMafalda OliveiraPaolo NucíforoDebra A. Patt
- Topics
- Cancer Treatment and Pharmacology (11 papers)Advanced Breast Cancer Therapies (9 papers)Breast Cancer Treatment Studies (7 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaCancer Research
- Partner nations
- SpainUnited StatesPalestinian Territory
In The Last Decade
Miguel Gil Gil
18 papers receiving 356 citations
Peers
Comparison fields: 5 of 42
- Oncology 249
- Cancer Research 138
- Pulmonary and Respiratory Medicine 135
- Molecular Biology 93
- Pathology and Forensic Medicine 44
Countries citing papers authored by Miguel Gil Gil
This map shows the geographic impact of Miguel Gil Gil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miguel Gil Gil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miguel Gil Gil more than expected).
Fields of papers citing papers by Miguel Gil Gil
This network shows the impact of papers produced by Miguel Gil Gil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miguel Gil Gil. The network helps show where Miguel Gil Gil may publish in the future.
Co-authorship network of co-authors of Miguel Gil Gil
This figure shows the co-authorship network connecting the top 25 collaborators of Miguel Gil Gil. A scholar is included among the top collaborators of Miguel Gil Gil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miguel Gil Gil. Miguel Gil Gil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 108 | |
| 7 | 3 | |
| 8 | 95 | |
| 9 | 1 | |
| 10 | Phase II study of a triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer. | 6 |
| 11 | 5 | |
| 12 | 26 | |
| 13 | 7 | |
| 14 | 46 | |
| 15 | 1 | |
| 16 | 43 | |
| 17 | 8 | |
| 18 | 3 | |
| 19 | 8 |
About Miguel Gil Gil
Miguel Gil Gil is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 19 papers that have together received 367 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (11 papers), Advanced Breast Cancer Therapies (9 papers) and Breast Cancer Treatment Studies (7 papers). The work is most often cited by research in Cancer Research (138 citations), Oncology (249 citations) and Pulmonary and Respiratory Medicine (135 citations). Miguel Gil Gil has collaborated with scholars based in Spain, United States and Palestinian Territory. Frequent co-authors include Lorena de la Peña, Steven J. Isakoff, Eva Ciruelos, Begoña Bermejo, José Luís Passos‐Coelho, Mafalda Oliveira, Paolo Nucíforo, Debra A. Patt, Cristina Saura and Isabel Calvo. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.